Hiv Vaccine Current Events | Hiv Vaccine News | 4
|
| Page
4 of
63 |
1256 Results |
|
|
|
Sort By:
Page Views | Date |
Results of landmark study of HIV vaccine published in the Lancet
Results from the Step study, a test-of-concept efficacy study of a Merck & Co., Inc. HIV vaccine candidate, were published online today in two papers in The Lancet. These analyses of the Step study are being conducted, presented and published to inform the continued search for an effective HIV vaccine. view more (2008-11-13)
Measles Vaccinations Need to be Repeated to Protect HIV-Infected Children
HIV-infected children may require repeat measles vaccination for protection, according to new research from the Johns Hopkins Bloomberg School of Public Health and other institutions. view more (2007-07-18)
Effective HIV control may depend on viral protein targeted by immune cells
An effective response of the immune system's 'killer' T cells against infection with HIV may depend on exactly which viral protein is targeted, according to an international group of researchers. view more (2006-12-18)
Cancer-causing virus associated with higher risk of new HIV infection
Infection with anal human papillomavirus (HPV), a virus that can cause anal and cervical cancers, is associated with a higher risk of new HIV infection in previously HIV-negative men who have sex with men (MSM), according to new UCSF research. view more (2009-05-01)
Vaccine shown effective against chancroid
HIV plagues more than 25 million people in sub-Saharan Africa, according to the World Health Organization, and efforts to develop a vaccine against the virus have achieved limited success. view more (2006-05-08)
New Therapeutic Vaccine for HIV/AIDS Eliminates Needles and Excessive Toxicity
DermaVir, a novel treatment for HIV/AIDS, offers a new option which complements and improves present drug therapies. The vaccine, applied topically to the skin, has demonstrated efficacy in boosting immune responses and controlling virus replication in chronically infected monkeys. This treatment possibly offers a new, non-invasive option for... view more... (2005-01-06)
Keeping young South Africans in school: A 'social vaccine' against AIDS
A study published today in the Journal of Epidemiology and Community Health suggests that secondary school attendance is linked to lower risk of HIV infection among young people in rural South Africa. view more (2008-01-17)
International study investigates early biology of HIV infection
In July 2005, the race to find a vaccine that would stem the worldwide rate of 13,000 new cases of HIV infection each day moved from competition among research institutions to a strategy of cooperation. view more (2006-05-02)
Scientists glimpse a rare human antibody which protects against AIDS
Scientists have obtained their first detailed glimpse of a rare antibody, called b12, which is capable of inactivating many different strains of HIV, the virus which causes AIDS. A crystal structure of b12 has been determined by scientists working at The Scripps Research Institute, California, and the Glycobiology Institute at Oxford University,... view more... (2001-08-08)
A natural approach for HIV vaccine
For 25 years, researchers have tried and failed to develop an HIV vaccine, primarily by focusing on a small number of engineered "super antibodies" to fend off the virus before it takes hold. view more (2009-03-16)
UQ research heralds vaccine technology breakthrough
Respiratory syncytial virus (RSV) infection is a widespread infant illness that has been linked to asthma and can be deadly but may be curable by the development of this new vaccine technology by the Sir Albert Sakzewski Virus Research Centre and The University of Queensland's Faculty of Biological and Chemical Sciences. view more (2007-05-09)
CHAVI announces international search for genes affecting HIV response
A pioneering collaboration among U.S., European and Australian researchers announced June 20, 2006, will seek to identify genetic differences in the way people respond to HIV. view more (2006-06-20)
Effects of bacterial pneumonia no worse for HIV-positive patients
Pneumonia doesn't appear to harm HIV-positive patients any more than those without HIV, according to a new international study conducted in part by the University of Alberta. view more (2005-09-28)
Healthy human immune system cells can respond to HIV-1
AIDS patients' failure to clear HIV-1 might not be due to the inability of the human immune system to recognise the virus, as was previously thought. view more (2006-05-18)
Monkeys vaccinated against SIV survive longer after infection
Results of two new studies sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), suggest that even if an HIV vaccine offers imperfect protection against the virus, it might provide vaccinated individuals with an important benefit: a significant survival advantage... view more... (2006-06-12)
Studies affirm need for influenza and measles vaccinations in HIV-infected patients
Two new studies emphasize the importance of delivering measles and influenza vaccines to HIV-infected individuals. Both studies are published in the August 1 issue of The Journal of Infectious Diseases, now available online. view more (2007-07-24)
Many pregnant women avoid HIV screening in Africa
'Prevention is the best cure' is a common expression, but what happens if preventative measures are not used? A large proportion of pregnant Ugandan women are going out of their way not to be HIV tested, increasing the risk of mother-to-child transmission. view more (2009-11-20)
Researchers have discovered a gene that can block the spread of HIV
A team of researchers at the University of Alberta, including a scientist at the University of Pennsylvania, have discovered a gene that is able to block HIV, and thought to in turn prevent the onset of AIDS. view more (2008-02-29)
Early-stage immune system control of HIV may depend on inherited factors
How well an individual's immune system controls HIV during the earliest phases of infection appears to depend on both the specific versions of key immune-system molecules called HLA Class I that have been inherited, as well as on the fragments of viral protein those molecules display to the T lymphocytes that usually destroy infected cells. view more (2006-11-06)
TB vaccine developed at McMaster University in Canada
McMaster University researchers are about to launch Canada's first tuberculosis (TB) vaccine clinical trial with a vaccine totally designed, manufactured and tested within McMaster. view more (2009-03-20)
|
|
| Page
4 of
63 |
1256 Results |
|
|
|
Sort By:
Page Views | Date |
|
